Quantcast
Home > Quotes > PTX
PTX

Pernix Therapeutics Holdings, Inc. Common Stock (PTX) Quote & Summary Data

$0.8399
*  
0.0494
6.25%
Get PTX Alerts
*Delayed - data as of Sep. 25, 2018 14:25 ET  -  Find a broker to begin trading PTX now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    PTX Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
$ 0.8301 / $ 0.84
Today's High / Low
$ 0.85 / $ 0.7909
Share Volume
465,120
50 Day Avg. Daily Volume
174,872
Previous Close
$ 0.7905
52 Week High / Low
$ 3.35 / $ 0.7601
Market Cap
11,691,630
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %

Intraday Chart

Shares Traded

Share Volume:
465,120
50 Day Avg. Daily Volume:
174,872

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
Earnings Per Share (EPS):
$ -5.06

Trading Range

The current last sale of $0.8399 is 10.50% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 0.85 $ 3.35
 Low: $ 0.7909 $ 0.7601

Company Description (as filed with the SEC)

We are a specialty pharmaceutical company focused on improving patients' lives by identifying, developing and commercializing differentiated products that address unmet medical needs. We target underserved segments, such as central nervous system (CNS) indications, including pain, neurology, and psychiatry, as well as other specialty therapeutic areas. We promote our core branded products to physicians through our sales force of 74 Sales Specialists and distribute our generic products through our wholly owned subsidiaries, Macoven Pharmaceuticals, LLC (Macoven) and Cypress Pharmaceuticals, Inc. ® (Cypress).  ... More ...  

Nasdaq Official Price

Open Price:
$ 0.80
Open Date:
Sep. 25, 2018
Close Price:
N/A
Close Date:
N/A

Research Brokers before you trade

Want to trade FX?

Analyst Info